Integral Health Asset Management, LLC Allogene Therapeutics, Inc. Transaction History

Integral Health Asset Management, LLC

  • $1.12 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$4.53 - $6.74 $31,710 - $47,180
7,000 Added 1.73%
412,000 $2.05 Million
Q1 2023

May 09, 2023
BUY
$4.92 - $8.21 $1.99 Million - $3.33 Million
405,000 New
405,000 $2 Million
Q2 2021

Aug 13, 2021
SELL
$23.49 - $35.8 $1.41 Million - $2.15 Million
-60,000 Closed
0 $0
Q1 2021

May 10, 2021
BUY
$25.79 - $39.02 $1.55 Million - $2.34 Million
60,000 New
60,000 $2.12 Million

Others Institutions Holding ALLO

# of Institutions
177
Shares Held
139M
Call Options Held
75.8K
Put Options Held
52.8K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $233M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Integral Health Asset Management, LLC Portfolio

Follow Integral Health Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email